The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update: Braltus (tiotropium): risk of inhalation of capsule if placed in the mouthpiece of the inhaler.
Actions for pharmacists and further information can be found on the MHRA website.